Free Trial

Extendicare Inc. Announces Jul 25 Dividend of $0.04 (TSE:EXE)

Extendicare logo with Medical background

Extendicare Inc. (TSE:EXE - Get Free Report) declared a jul 25 dividend on Thursday, July 31st, RTT News reports. Shareholders of record on Friday, August 15th will be paid a dividend of 0.042 per share on Friday, August 15th. This represents a yield of 3.81%. The ex-dividend date of this dividend is Thursday, July 31st.

Extendicare Stock Performance

EXE stock traded down C$0.21 during midday trading on Tuesday, hitting C$13.03. The company's stock had a trading volume of 97,854 shares, compared to its average volume of 182,128. The stock's 50-day moving average price is C$14.10 and its 200 day moving average price is C$12.73. The company has a quick ratio of 0.98, a current ratio of 0.62 and a debt-to-equity ratio of 283.02. Extendicare has a 1 year low of C$7.21 and a 1 year high of C$15.24. The stock has a market cap of C$1.09 billion, a price-to-earnings ratio of 16.61 and a beta of 1.26.

Analysts Set New Price Targets

A number of analysts recently issued reports on EXE shares. BMO Capital Markets boosted their price objective on Extendicare from C$13.50 to C$14.50 in a research note on Monday, May 12th. TD Securities boosted their price objective on Extendicare from C$13.00 to C$15.00 and gave the company a "hold" rating in a research note on Thursday, May 22nd.

Get Our Latest Report on Extendicare

About Extendicare

(Get Free Report)

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.

Read More

Dividend History for Extendicare (TSE:EXE)

Should You Invest $1,000 in Extendicare Right Now?

Before you consider Extendicare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.

While Extendicare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines